These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 9783897)
1. G protein abnormalities in pituitary adenomas. Spada A; Lania A; Ballarè E Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897 [TBL] [Abstract][Full Text] [Related]
2. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations. Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813 [TBL] [Abstract][Full Text] [Related]
3. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141 [TBL] [Abstract][Full Text] [Related]
4. [Genetic changes in human pituitary adenomas]. Spada A; Lania A Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361 [TBL] [Abstract][Full Text] [Related]
5. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis. Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229 [TBL] [Abstract][Full Text] [Related]
6. Impact of gsp oncogene on the expression of genes coding for Gsalpha, Pit-1, Gi2alpha, and somatostatin receptor 2 in human somatotroph adenomas: involvement in octreotide sensitivity. Barlier A; Pellegrini-Bouiller I; Gunz G; Zamora AJ; Jaquet P; Enjalbert A J Clin Endocrinol Metab; 1999 Aug; 84(8):2759-65. PubMed ID: 10443675 [TBL] [Abstract][Full Text] [Related]
7. G-proteins and hormonal signalling in human pituitary tumors: genetic mutations and functional alterations. Spada A; Vallar L; Faglia G Front Neuroendocrinol; 1993 Jul; 14(3):214-32. PubMed ID: 8102338 [TBL] [Abstract][Full Text] [Related]
8. GNAS imprinting and pituitary tumors. Mantovani G; Lania AG; Spada A Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas. Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759 [TBL] [Abstract][Full Text] [Related]
10. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation. Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic role of heterotrimeric G proteins. Vallar L Cancer Surv; 1996; 27():325-38. PubMed ID: 8909808 [TBL] [Abstract][Full Text] [Related]
12. G-protein oncogenes in acromegaly. Spada A; Vallar L Horm Res; 1992; 38(1-2):90-3. PubMed ID: 1306524 [TBL] [Abstract][Full Text] [Related]
13. Gs protein mutations and the pathogenesis and function of pituitary tumors. Harris PE Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404 [TBL] [Abstract][Full Text] [Related]
14. G protein mutations in pituitary tumors: a study on Turkish patients. Kan B; Esapa C; Sipahi T; Nacar C; Ozer F; Sayhan NB; Kaynar MY; Sarioğlu AC; Harris PE Pituitary; 2003 Sep; 6(2):75-80. PubMed ID: 14703016 [TBL] [Abstract][Full Text] [Related]
15. Genetics of pituitary tumors: Focus on G-protein mutations. Lania A; Mantovani G; Spada A Exp Biol Med (Maywood); 2003 Oct; 228(9):1004-17. PubMed ID: 14530508 [TBL] [Abstract][Full Text] [Related]
16. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene. Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215 [TBL] [Abstract][Full Text] [Related]
17. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. Tordjman K; Stern N; Ouaknine G; Yossiphov Y; Razon N; Nordenskjöld M; Friedman E J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579 [TBL] [Abstract][Full Text] [Related]
18. Genetic aspects of pituitary tumors. Spada A J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1213-6; discussion 1261-2. PubMed ID: 11964015 [TBL] [Abstract][Full Text] [Related]
19. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors. Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782 [TBL] [Abstract][Full Text] [Related]
20. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors. Shi Y; Tang D; Deng J; Su C Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]